Day One Biopharmaceuticals (DAWN) IPO Opens 56% Higher

Go back to Day One Biopharmaceuticals (DAWN) IPO Opens 56% Higher

Day One Biopharmaceuticals (DAWN) Prices 10M Share Upsized IPO at $16/Sh

May 27, 2021 6:12 AM EDT

Day One Biopharmaceuticals (NASDAQ: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers, today announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price... More